Kopran Stock Plummets to New 52-Week Low of Rs. 141.35

Kopran, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs. 141.35 today, November 14, 2025. This decline marks a significant downturn for the stock, which has seen a 36.24% decrease in value over the past year, contrasting sharply with the Sensex's positive performance of 8.52% during the same period.
The stock's recent performance has been characterized by a trend reversal, gaining after three consecutive days of decline. However, it continues to trade below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.

Kopran's financial metrics reveal a challenging landscape, with a notable drop in net sales of 22.2% and a negative profit after tax of Rs. -9.92 crore, reflecting a staggering decline of 234.4%. The company's operating profit has also contracted at an annual rate of 11.79% over the last five years, contributing to its underperformance relative to broader market indices.

Despite its low debt-to-equity ratio of 0.23, Kopran's long-term growth prospects appear limited, as evidenced by its consistent negative results over the past five quarters.